CPE and myeloid sarcoma: A small study in southern Europe found no evidence of increased prevalence of islet autoantibody positivity (GADA, IA‐2A, or carboxypeptidase H autoantibodies) in serum samples of 49 individuals with MS compared with known general population levels (Table 3) [63].